Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Country / region: Brazil Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20214
20224
20236
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed5
Recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federal University of Paraíba3
University of Nove de Julho3
University of Sao Paulo2
Cardresearch1
Centro Universitário Augusto Motta1
D'Or Institute for Research and Education1
Douglas D. Fraser1
Federal University of ABC1
Federal University of São Paulo1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome21
COVID-1910
Cognitive Dysfunction2
Fatigue2
Respiratory Tract Infections2
Cardiovascular Abnormalities1
Cardiovascular Diseases1
Chronic Pain1
Coronavirus Infections1
Fatigue Syndrome, Chronic1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.